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Summary
Neuromodulators determine how neural circuits process in-
formation during cognitive states such as wakefulness,
attention, learning, andmemory [1]. fMRI can provide insight
into their function and dynamics, but their exact effect on
BOLD responses remains unclear [2–4], limiting our ability
to interpret the effects of changes in behavioral state using
fMRI. Here, we investigated the effects of dopamine (DA) in-
jections on neural responses and haemodynamic signals in
macaque primary visual cortex (V1) using fMRI (7T) and in-
tracortical electrophysiology. Aside from DA’s involvement
in diseases such as Parkinson’s and schizophrenia, it also
plays a role in visual perception [5–8]. Wemimicked DAergic
neuromodulation by systemic injection of L-DOPA and Car-
bidopa (LDC) or by local application of DA in V1 and found
that systemic application of LDC increased the signal-to-
noise ratio (SNR) and amplitude of the visually evoked
neural responses in V1. However, visually induced BOLD re-
sponses decreased, whereas cerebral blood flow (CBF)
responses increased. This dissociation of BOLD and CBF
suggests that dopamine increases energy metabolism by a
disproportionate amount relative to the CBF response,
causing the reduced BOLD response. Local application of
DA in V1 had no effect on neural activity, suggesting that
the dopaminergic effects are mediated by long-range inter-
actions. The combination of BOLD-based and CBF-based
fMRI can provide a signature of dopaminergic neuromodula-
tion, indicating that the application of multimodal methods
can improve our ability to distinguish sensory processing
from neuromodulatory effects.Results
We combined fMRI with neurophysiology and pharmacology
in five anesthetized nonhuman primates (Macaca mulatta),*Correspondence: daniel.zaldivar@tuebingen.mpg.de (D.Z.), jozien.
goense@glasgow.ac.uk (J.G.)from which we acquired blood-oxygen-level-dependent
(BOLD), functional cerebral blood flow (fCBF), and electro-
physiology data while the animals viewed a rotating checker-
board stimulus. Figure 1A shows the experimental paradigm.
We pharmacologically mimicked dopaminergic (DAergic) neu-
rotransmission by systemic application of L-DOPA and Carbi-
dopa (LDC). Carbidopa inhibits the breakdown of L-DOPA in
the periphery, thereby preventing systemic changes in cere-
bral blood volume (CBV) that may affect the fMRI results (Fig-
ure S1 available online). The lack of systemic effects of the LDC
injection is evidenced by the highly stable physiological pa-
rameters during and after injection (Table S1).
Evoked BOLD and Neural Responses under Systemic LDC
Figure 1B shows representative fMRI responses in primary
visual cortex (V1) to visual stimulation. Figure 1C shows the
changes in the BOLD response over the course of the LDC in-
jection. BOLD modulation in the predrug period was 2.5% 6
1.1%, which is typical for anesthetized monkeys at 7T [9–11].
During the drug infusion, we observed a significant reduction
in the visually induced modulation (Figures 1C and 1D;
MODdrug = 50%6 5.3%; p = 0.034), which was sustained after
the infusion was stopped (MODpost = 60% 6 4.2%; p = 0.05).
No significant changes in the baseline were found (Figure 1D).
We recorded local field potentials (LFPs) and multiunit
spiking activity (MUA) to evaluate the effects of LDC applica-
tion on neural activity. The power in the following three dif-
ferent frequency ranges was calculated: g (40–150 Hz), MUA
(900–3,000 Hz), and q (4–8 Hz). g and MUA ranges were most
strongly correlated with the BOLD signal [2, 3, 12], whereas q
was used to indicate whether LDC affects the broadband-
LFP power and to assess whether dopamine (DA) injection in-
duces changes in the level of anesthesia. Figures 2A–2C show
the average time course across experiments for the q, g, and
MUA bands, respectively. LDC application resulted in an
18% increase in visual modulation in the g band (Figure 2D;
MODg,drug = 118% 6 4.2%; p = 0.024) and a 19% increase in
the MUA band (MODMUA,drug = 119%6 5%; p = 0.031). The ef-
fect of LDC on the MUA amplitude reached baseline values
w4.5 min after the infusion was stopped. In contrast, for the
g band, the increase in visually induced modulation was long
lasting and started to reduce w12 min after the infusion was
stopped. Additionally, we observed an increase in the signal-
to-noise ratio (SNR) of the g andMUAbands starting shortly af-
ter LDC injection (Figure 2E); the response to the stimulus
increased, whereas the variability decreased (Figures 2B and
2C). The SNR in the g band (SNRg,drug = 13.7 dB 6 2.0 dB;
p = 0.011) kept increasing after the infusion was stopped
(SNRg,post = 14.7 dB 6 2.0 dB; p = 0.012). The MUA band
also showed an SNR increase after the start of the injection
(SNRMUA,drug = 12.2 dB 6 2.2 dB; p = 0.012), which continued
until the end of the trial (SNRMUA,post = 11.0 dB 6 2.0 dB; p =
0.026). In the q band (Figure 2A), neither visually induced mod-
ulation nor SNR changed upon LDC infusion.
DA Effects Are Not Locally Induced in V1
We next investigated whether the increases in neural activity
are locally induced in V1 or are due to a remote influence
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Figure 1. BOLD Responses under L-DOPA and Carbidopa Influence in Visual Cortex
(A) Experimental paradigm and design. The stimulus was a rotating checkerboard of 48 s followed by an isoluminant blank screen of 48 s (right). Every exper-
iment was divided into three conditions: (1) a 12.8 min experiment without pharmacological manipulation, (2) a 12.8 min session with Carbidopa precondi-
tioning (1.5 mg/kg diluted in 50ml of PBS and injected at 1.1ml/min), and (3) a 46min session consisting of LDCmanipulation (2.1 mg/kg + 0.5 mg/kg diluted
in 50 ml of PBS and injected at 1.1 ml/min over a period of 12 min).
(B) Activation maps showing voxels with a significant response to the visual stimulus (eight-shot GE-EPI; FOV: 723 72 mm2; TE/TR: 20/3,000 ms; flip angle
90; matrix: 96 3 96), overlaid on an anatomical scan (FLASH), acquired at 7T with an in-plane resolution of 0.75 3 0.75 mm2 and 2 mm slice thickness.
(C) The average BOLD time course (928 volumes) over 18 fMRI experimental sessions (five animals) shows a decrease in visually induced modulation by
L-DOPA and Carbidopa; the green and the red lines show the start and stop of the L-DOPA-Carbidopa infusion.
(D) The average BOLD response to the visual stimulus (left), decreased by 50% compared to the predrug period, whereas the baseline did not change under
L-DOPA and Carbidopa (right). The shaded areas represent the SE.
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2806from other regions by injecting DA intracortically in V1 to deter-
mine whether this induces similar effects as systemic DA. Fig-
ures 3A–3C show the averaged traces of the q, g, and MUA
bands during intracortical application of DA (5 mM) and
show no discernible changes. Visually induced modulation in
the g and MUA bands (Figure 3D) was unchanged (p = 0.23).
The SNR of the g and MUA bands also remained unchanged
during the experimental session (Figure 3E; SNRg,drug = 9.0
dB 6 1.5 dB; p = 0.31; SNRg,post = 8.8 dB 6 2.0 dB; p = 0.13;
SNRMUA,drug = 10.1 dB 6 0.5 dB; p = 0.18; SNRMUA,post = 10.8dB 6 2.0 dB; p = 0.18). Because different concentrations of
DA can exert multiple modes of action [13], we tested whether
different concentrations of intracortical DA affected the re-
sponses in V1. However, no concentration-dependent effects
were observed (Figure S2).
The Effects of LDC on CBF Suggest an Increase in Energy
Expenditure
Stimulus-induced increases in g power and in MUA occurred



















































































Figure 2. Systemic Application of L-DOPA and
Carbidopa Increases Neural Responses in V1
Average time course of the neural activity (LFP and
MUA bands) across experiments in response to L-
DOPA and Carbidopa injection (n = 16).
(A) q LFP band (4–8 Hz).
(B) g LFP band (40–150 Hz).
(C) MUA band (900–3,000 Hz). The green and red
lines denote the beginning and end of the systemic
LDC infusion. In the MUA and g bands, the ampli-
tude of the visual response increased after LDC,
whereas the variability of the baseline decreased.
(D) Percentage change in visual response of the
g band (blue) and MUA (red).
(E) The SNR of the g band (blue) and the MUA (red)
increased upon DA infusion. No changes were
observed in the q band.
The shaded areas represent the SE.
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2807resolve this potential discrepancy, we measured fCBF using
arterial spin labeling (ASL). Figure 4A shows fCBF in early visual
cortex, and Figure 4B shows the averaged time course of the
CBF across experiments. Therewas a reliable, visually induced
CBF modulation of 19% 6 7% during the predrug period, in
agreement with earlier studies [11]. During the ‘‘drug’’ period,
we observed an increase in modulation by 34% (MODdrug =
134% 6 10%; p = 0.045). The maximum CBF increase of 43%
was observed w12 min after the infusion started and lasted
w20 min (MODpost = 143% 6 10%; p = 0.034). We also
observed significant increases in baseline CBFduring and after
the injection. An increase in the baseline was evidentw8 min
after the start of the injection (CBFbaseline,drug = 128% 6 5.2%;
p = 0.022). The time course of the CBF changes upon LDC in-
jection were similar to the time courses of the changes in the
neuronal responses, suggesting that increases in neural activ-
ity may cause the CBF increases.
Discussion
Using BOLD-based and CBF-based fMRI combined with
intracortical electrophysiology, we found that DAergic neuro-
modulation increased neural and CBF responses to a visual
stimulus, whereas it decreased the BOLD response. Neuromo-
dulators can exert strong influences on neural responses and
alter neurovascular coupling [1, 3]. Our results show thatchanges in the BOLD fMRI signal alone
cannot be used to make inferences about
increases or decreases in the underlying
neural activity.
Neurophysiological Effects of DA
Injection
Neurophysiological recordings under
systemic LDC injection showed an in-
crease in the amplitude and SNR of visu-
ally evoked responses. DA has been
shown to improve the SNR in prefrontal
cortex (PFC) and in sensory areas,
including V1 [8, 14–16], thereby changing
detection performance at the behavioral
level [8, 16–18]. Increased neuronal activ-
ity in V1 has been shown to predict the
timing of reward delivery, even when thecells were not driven by a visual stimulus [8, 18], highlighting
the importance of DA for extracting behaviorally relevant infor-
mation [17, 19].
However, local dopamine application did not change neural
activity, in good agreement with the low density and sparse
distribution of dopamine receptors (DARs) in V1 [20], suggest-
ing that DA does not exert its effects on V1 itself. The increase
in neural activity upon systemic DA may be mediated by long-
range interactions from higher-order regions (e.g., frontal re-
gions) [5, 15]. Large-scale interactions have been reported in
other sensory modalities, including the visual, somatosensory,
and auditory systems, suggesting that DAprepares the higher-
order area for the processing of incoming sensory signals and
promotes the readout of task-related information [14–16].
Manipulation of prefrontal D1 receptors increased the magni-
tude, reliability, and selectivity of neuronal responses in V4
[5], and similar mechanisms may play a role in V1.
The lack of DAergic effects upon local application is contrary
to the inhibitory responses observed earlier [21, 22]. Although
DA can exert different actions depending on concentration
[13], none of the DA concentrations used in this study changed
the amplitude or SNR of the visually evoked responses. Aside
from species differences [20, 23], another possibility that could
explain the differences is that the earlier experiments were per-
formedwith solutions inwhich thepHwas not tightly controlled,

















































































Figure 3. Local Application of DA Does Not Alter
Neural Responses in V1
Average time course of the neural activity (LFP and
MUA bands) across experiments, in response to
local application of DA (n = 10; DA was diluted in
artificial cerebrospinal fluid to a final concentration
of 5 mM).
(A) q LFP band (4–8 Hz).
(B) g LFP band (40–150 Hz).
(C) MUA band (900–3,000 Hz). The green and red
lines denote the beginning and end of the DA infu-
sion. In the MUA and g bands, the amplitude of the
visual response was not affected by DA infusion.
(D) Percentage change in visual response of the
g (blue) band and MUA (red).
(E) The SNR of the g band (blue) and the MUA (red)
shows no changes upon DA. No changes were
observed in the q band.
The shaded areas represent the SE.
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Our finding of a decrease in the evoked BOLD response and an
increase in the CBF response upon systemic LDC injection ex-
tends previous observations in humans and macaques in
which fMRI responses in V1 decreased with cues that predict
and anticipate reward [6, 19]. A decrease in BOLD responses
in V1 while behavioral performance improved after an acute
dose of L-DOPAwas seen in studies of amblyopia [7, 25]. How-
ever, BOLD increases have also been observed in humans in
primary auditory and somatosensory cortex after DA agonist
administration [26, 27]. These differences in BOLD responses
upon DAergic neuromodulation can be partly explained by
the difference in densities of DARs and DA innervation be-
tween cortical regions. DARs and DA innervations decrease
along a rostral-caudal gradient, having the highest density in
PFC and the lowest (or almost nonexistent) in occipital cortex
[20]. Thus, BOLD responses toDAergic neuromodulation could
differ in various sensory cortices because local influences of
DA on the vasculature maymodulate the blood supply [28, 29].
The effects of DA on the hemodynamic signals have been
extensively addressed using different pharmacological agents
in rats and monkeys [29–33]. For instance, amphetamines
decreased CBV responses in occipital regions [33]. However,
amphetamines are known to increase DA levels as well as alter
the kinetics of other neurochemicals that affect the regionalCBV [34], whereas CBV responses may
differ fromBOLD responses [35]. Different
DARs exert different effects on the hemo-
dynamic signals [30]; stimulation of D1 re-
ceptors (D1Rs) increases CBV and BOLD
responses [30, 32], whereas blocking
these receptors decreases them [30, 36].
The activation and deactivation of D2
receptors (D2Rs) produce opposite ef-
fects [37]. The present study did not
consider receptor-specific responses but
instead focused on understanding the




Changes in the LFP are usually mir-
rored by changes in spiking and in thehaemodynamic responses [3, 12]. Our observation of a disso-
ciation between the BOLD and neurophysiological responses
indicates that neurovascular coupling may differ under states
of neuromodulation. Our results suggest that the increase in
neural activity and CBF and the decrease in BOLD signal are
caused by a disproportionate increase in O2 consumption
due to DAergic neuromodulation. The BOLD signal reflects
the deoxyhemoglobin concentration (dHb concentration) and
is affected by CBF, CBV, and the cerebral metabolic rate of
oxygen consumption (CMRO2). The stimulus-evoked BOLD
decrease could be due to a CBF decrease or a dHb concentra-
tion increase after dopamine application. Because CBF
increased, dHb production most likely also increased, i.e., an
increase in CMRO2. An increase in CBF modulation and a
decrease in BOLD response can occur when the O2 consump-
tion increases by a proportionally larger amount than the
inflow of fresh blood, leading to a relative increase in dHb
concentration and a decrease in the BOLD signal compared
to the preinjection response.
The increased neural activity also suggests a CMRO2 in-
crease because it has been shown that improving neurons’
sensitivity is energetically draining [17, 38]. Autoradiography
has also shown that the application of L-DOPA increases brain
metabolism [39]. These observations are not surprising given
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Figure 4. CBF Increases with L-DOPA and Carbi-
dopa
(A) Activation patterns of functional CBF (using
flow-sensitive alternating inversion recovery) in
early visual cortex (monkey A09) in response to
visual stimulation.
(B) The average time course over six CBF ex-
perimental sessions shows an increase in base-
line-induced as well as visually induced CBF
(six sessions acquired at 7T: TI, 1,400 ms; slab
6 mm; FOV, 5.5 3 2.4 mm2; TE/TR, 9.5/
4,500ms; BW, 150 kHz, and one session acquired
at 4.7T: TI, 1,400ms; slab 6mm; FOV, 63 3.2mm2
; TE/TR, 9.1/4,500 ms; BW, 125 kHz).
(C) The average visually induced modulation
increased by 43% (left) and the baseline changed
by 31% (right) upon L-DOPA and Carbidopa infu-
sion. The shaded areas represent the SE.
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2809[3, 38]. The increase in CBF likely relates to neural activity
because glucose metabolism, CMRO2, and CBF are closely
coupled [3, 40]. Increased neural activity in response to reward
increases has been shown to increase the CBF [41].
The increased baseline CBF upon acute LDC injection
commonly seen in humans and nonhuman primates
[42–44] is usually attributed to vasodilation. However, the
stimulus-induced CBF increases cannot be attributed to
vasodilation alone. Vasodilation increases the baseline
CBF and BOLD signals and reduces stimulus-evoked CBF
and BOLD signals due to limited reserves, as seen in the
case of hypercapnia (a potent vasodilator) [45, 46]. The pos-
sibility that the BOLD reduction is due to a ceiling effect, as
seen in the case of hypercapnia or in pathology, is therefore
unlikely because evoked CBF decreases in the case of
vasodilation (e.g., in hypercapnia) or an inadequate CBF
response [47].
Positron emission tomography studies have shown little or
no change in CMRO2 upon L-DOPA administration [43], the
latter reflecting little or no change in baseline response, as
was observed here. A lack of CMRO2 increase, however,
would not be able to explain our stimulus-driven results:
comparing them again with hypercapnia, where CMRO2 and
neural activity do not change considerably, this would lead
to very different CBF and BOLD responses to the stimulus
than observed here [45]. Whether the increase in baseline
CBF corresponds to an increase in metabolism cannot be
deduced based on the current data. The baseline of the
BOLD time course did not change, with a minor tendency to
go down. It is possible that the increase in CBF is balanced
out by an increase in dHb concentration in the baseline state,
leading to little or no net baseline changes. Following the same
reasoning as with the stimulus-induced responses, the small
decrease in the baseline BOLD trace may indicate a smallincrease in CMRO2 in the baseline con-
dition as well. However, further study is
needed to verify this.
The effects observed here are unlikely
to be due to DA-induced changes in the
level of anesthesia because no differ-
ences were observed in the q band or
the physiological parameters. The ad-
vantage of using anesthetized animals
is that we could assess the effect of do-
pamine on neural and hemodynamicproperties without needing to take behavioral parameters like
attention, reward, and anticipation into account. Anesthetized
animals also allow us to discriminate small changes because
the anesthetized model allows for longer averaging times and
higher SNR. However, differences in regional CBF under
DAergic influence have been observed between awake and
anesthetized animals [42], and differences may depend on
the type of anesthesia. Because neuromodulatory properties
strongly depend on the animal’s behavioral state, including its
level of alertness, this highlights the complexity of fMRI studies
of neuromodulation, and it would be ideal to have a comparison
of dopaminergic effects in awake and anesthetized animals.
The findings presented here provide us with a better under-
standing of the influence of neuromodulation on fMRI signals.
The decrease of the BOLD signal in the face of increased en-
ergy use implies that the BOLD response may not always
faithfully reflect the neural responses under neuromodulation
and that caution is necessary in interpreting BOLD signals un-
der neuromodulation. Combining BOLD measurements with
CBF and/or CBV measurements can resolve these complex-
ities and potentially provide a tool to discriminate sensory
processing from neuromodulation. Such multidisciplinary ap-
proaches may improve the interpretation of fMRI studies
where neuromodulation plays a role, for example, in studies
of reward or attention, and also facilitate clinical applications
of fMRI.
Experimental Procedures
fMRI and electrophysiology data were collected from six (four females)
healthy rhesus monkeys (Macaca mulatta; 5–11 kg, 6–12 years old). All
experimental procedures were carried out under approval of the local au-
thorities (Regierungspra¨sidium, Baden-Wu¨rttemberg, Tu¨bingen, Germany,
Project KY4/09) and were in full compliance with the guidelines of the Euro-
pean Community (EUVD 86/609/EEC).
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Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, two figures, and one table and can be found
with this article online at http://dx.doi.org/10.1016/j.cub.2014.10.006.
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